CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,078,398 | -5.8% | 94,027 | +18.8% | 0.01% | -12.5% |
Q1 2024 | $5,392,819 | +7.6% | 79,120 | -1.2% | 0.02% | -5.9% |
Q4 2023 | $5,013,947 | +48.3% | 80,095 | +7.5% | 0.02% | +30.8% |
Q3 2023 | $3,380,375 | -18.1% | 74,474 | +1.2% | 0.01% | -18.8% |
Q2 2023 | $4,129,546 | +118225.1% | 73,558 | -4.7% | 0.02% | +6.7% |
Q1 2023 | $3,490 | +6.3% | 77,176 | -4.4% | 0.02% | -6.2% |
Q4 2022 | $3,283 | -99.9% | 80,766 | -15.4% | 0.02% | -50.0% |
Q3 2022 | $6,235,000 | +571.9% | 95,432 | +524.3% | 0.03% | +540.0% |
Q2 2022 | $928,000 | -37.6% | 15,286 | -35.6% | 0.01% | -28.6% |
Q1 2022 | $1,488,000 | -17.0% | 23,718 | +0.2% | 0.01% | -12.5% |
Q4 2021 | $1,792,000 | -6.3% | 23,662 | +38.4% | 0.01% | -20.0% |
Q3 2021 | $1,912,000 | +233.7% | 17,093 | +382.4% | 0.01% | +233.3% |
Q2 2021 | $573,000 | +2.3% | 3,543 | -22.9% | 0.00% | -25.0% |
Q1 2021 | $560,000 | -37.3% | 4,596 | -21.3% | 0.00% | -42.9% |
Q4 2020 | $893,000 | +136.9% | 5,838 | +29.2% | 0.01% | +75.0% |
Q3 2020 | $377,000 | +38.1% | 4,517 | +21.6% | 0.00% | +33.3% |
Q2 2020 | $273,000 | +279.2% | 3,715 | +116.6% | 0.00% | +200.0% |
Q1 2020 | $72,000 | -35.7% | 1,715 | -7.1% | 0.00% | 0.0% |
Q4 2019 | $112,000 | +45.5% | 1,847 | -1.3% | 0.00% | 0.0% |
Q3 2019 | $77,000 | -17.2% | 1,872 | -5.4% | 0.00% | 0.0% |
Q2 2019 | $93,000 | +31.0% | 1,979 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $71,000 | +24.6% | 1,979 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $57,000 | -35.2% | 1,979 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $88,000 | -24.1% | 1,979 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $116,000 | – | 1,979 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |